Pluracidomycin C1

Pluracidomycin C1 is a carbapenem antibiotic. Pluracidomycin C1 has anti-Gram-positive bacteria and Gram-negative bacteria activity, and has the effect of inhibiting β-lactamase[1].

Product Specifications

CAS Number

[82138-66-7]

UNSPSC

12352211

Target

Antibiotic; Bacterial

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Infection

Smiles

O=S(O[C@H]([C@@]1([H])[C@]2([H])N(C1=O)C(C(O)=O)=C(C2)S(C(O)O)=O)C)(O)=O

Molecular Formula

C10H13NO10S2

Molecular Weight

371.34

References & Citations

[1]T Yoshida, et al. Therapeutic effect of SF-2103A, a novel carbapenem antibiotic, in combination with cefotaxime, cefoperazone and other cephalosporins. J Antibiot (Tokyo) . 1986 Jul;39 (7) :956-65.